Agustin Avilés

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Activities & Behaviors

Actuarial Analysis

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Avilés Agustin; Nambo M Jesús; Cleto Sergio; Neri Natividad; Huerta-Guzmán Judith
Rituximab and dose-dense chemotherapy in primary testicular lymphoma.
Avilés Agustin; Castañeda Claudia; Cleto Sergio; Neri Natividad; Huerta-Guzmán Judith; Gonzalez Martha; Nambo Maria-Jesús
Rituximab and chemotherapy in primary gastric lymphoma.
Avilés Agustin; Castañeda Claudia; Neri Natividad; Cleto Sergio; Talavera Alejandra; González Martha; Huerta-Guzmán Judith; Nambo M Jesús
Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Agustin Avilés (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Avilés Agustin; Nambo M Jesús; Cleto Sergio; Neri Natividad; Huerta-Guzmán Judith
Rituximab and dose-dense chemotherapy in primary testicular lymphoma.
Clinical lymphoma & myeloma 2009;9(5):386-9.
2009: Avilés Agustin; Castañeda Claudia; Cleto Sergio; Neri Natividad; Huerta-Guzmán Judith; Gonzalez Martha; Nambo Maria-Jesús
Rituximab and chemotherapy in primary gastric lymphoma.
Cancer biotherapy & radiopharmaceuticals 2009;24(1):25-8.
2008: Avilés Agustin; Castañeda Claudia; Neri Natividad; Cleto Sergio; Talavera Alejandra; González Martha; Huerta-Guzmán Judith; Nambo M Jesús
Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified.
Medical oncology (Northwood, London, England) 2008;25(3):360-4.
2007: Avilés Agustin; Nambo M Jesús; Neri Natividad; Castañeda Claudia; Cleto Sergio; Gonzalez Martha; Huerta-Guzmán Judith
Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome.
Cancer biotherapy & radiopharmaceuticals 2007;22(6):836-40.
2007: Avilés Agustin; Castañeda Claudia; Neri Natividad; Cleto Sergio; Nambo M Jesús
Rituximab and dose dense chemotherapy in primary breast lymphoma.
Haematologica 2007;92(8):1147-8.
2007: Avilés Agustin; Cleto Sergio; Castañeda Claudia; Nambo Maria Jesús
CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.
Hematology (Amsterdam, Netherlands) 2007;12(3):241-4.
2007: Avilés Agustin; Nambo María Jesus; Castañeda Claudia; Cleto Sergio; Neri Natividad; Murillo Edgar; Huerta-Guzmán Judith; Contreras Margarita
Rituximab and escalated chemotherapy in elderly patients with aggressive diffuse large-cell lymphoma: a controlled clinical trial.
Cancer biotherapy & radiopharmaceuticals 2007;22(2):194-9.
2007: Avilés Agustin; Nambo María J; Neri Natividad; Castañeda Claudia; Cleto Sergio; Huerta-Guzmán Judith
Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma.
Medical oncology (Northwood, London, England) 2007;24(2):227-30.
2007: Avilés Agustin; Nambo María J; Neri Natividad; Cleto Sergio; Castañeda Claudia; Huerta-Guzmàn Judith; Murillo Edgar; Contreras Margarita; Talavera Alejandra; González Martha
Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14 +R) in high-risk diffuse large cell lymphoma.
Medical oncology (Northwood, London, England) 2007;24(1):85-9.
2006: Madrigal-Velázquez Mónica; Avilés Agustín; Neri Natividad; Huerta Judith; Martínez-Jaramillo Guadalupe; Mayani Héctor
Expression of ice, bcl-2, c-myc and p53 in different bone marrow cell populations from patients with diffuse large B-cell lymphoma.
Leukemia & lymphoma 2006;47(4):665-73.
2006: Avilés A; Neri N; Nambo M J
Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):286-8.
2006: Avilés Agustin; Neri Natividad; Calva Angel; Huerta-Guzmán Judith; Cleto Sergio; Nambo M Jesús
Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit.
Oncology 2006;70(3):173-6.
2006: Avilés Agustín; Neri Natividad; Nambo M Jesús; Huerta-Guzman Judith; Cleto Sergio
Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.
Medical oncology (Northwood, London, England) 2006;23(2):295-300.
2005: Avilés Agustin; Neri Natividad; Nambo M Jesús; Cleto Sergio; Castañeda Claudia; González Martha; Talavera Alejandra; Huerta-Guzmán Judith
Novel therapy in multiple myeloma.
Investigational new drugs 2005;23(5):411-5.
2005: Avilés Agustin; Neri Natividad; Nambo Jesús M; Huerta-Guzman Judith; Talavera Alejandra; Cleto Sergio
Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy.
Leukemia & lymphoma 2005;46(7):1023-8.
2005: Avilés A; Nambo M J; Neri N; Murillo E; Castañeda C; Cleto S; Talavera A; González M
Biological modifiers as cytoreductive therapy before stem cell transplant in previously untreated patients with multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):219-21.
2005: Avilés Agustin; Neri Natividad; Delgado Serafin; Pérez Felipe; Nambo M Jesús; Cleto Sergio; Talavera Alejandra; Huerta-Guzmán Judith
Residual disease after chemotherapy in aggressive malignant lymphoma: the role of radiotherapy.
Medical oncology (Northwood, London, England) 2005;22(4):383-7.
2005: Avilés Agustin; Delgado Serafin; Nambo M Jesús; Neri Natividad; Murillo Edgar; Cleto Sergio
Primary breast lymphoma: results of a controlled clinical trial.
Oncology 2005;69(3):256-60.
2005: Avilés Agustin; Nambo María Jesús; Neri Natividad; Talavera Alejandra; Cleto Sergio
Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial.
Medical oncology (Northwood, London, England) 2005;22(1):57-62.
2004: Avilés Agustin; Neri Natividad; Huerta-Guzmán Judith; Pérez Felipe; Sotelo León
Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma.
Leukemia & lymphoma 2004;45(11):2247-51.
2004: Avilés Agustin; Fernándezb Raúl; Pérez Felipe; Nambo M Jesús; Neri Natividad; Talavera Alejandra; Castañeda Claudia; González Martha; Cleto Sergio
Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome.
Leukemia & lymphoma 2004;45(7):1385-9.
2004: Avilés Agustin; Nambo M Jesús; Neri Natividad; Huerta-Guzmán Judith; Cuadra Ivonne; Alvarado Isabel; Castañeda Claudia; Fernández Raúl; González Martha
The role of surgery in primary gastric lymphoma: results of a controlled clinical trial.
Annals of surgery 2004;240(1):44-50.
2004: Martínez-Jaramillo Guadalupe; Avilés Agustín; Neri Natividad; Huerta Judith; Madrigal-Velazquez Mónica; Flores-Guzmán Patricia; Mayani Hector
In vitro proliferation and expansion of hematopoietic progenitors from patients with diffuse large B-cell lymphoma before and after chemotherapy.
Leukemia & lymphoma 2004;45(6):1247-54.
2004: Avilés Agustin; Neri Natividad; Nambo M Jesús; Castañeda Claudia; Talavera Alejandra; Huerta-Guzmán Judith; Murillo Edgar
Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphoma.
Stem cells and development 2004;13(2):205-9.
2004: Avilés Agustin; Neri Natividad; Huerta-Guzmán Judith; Pérez Felipe; Fernández Raúl
Testicular lymphoma: organ-specific treatment did not improve outcome.
Oncology 2004;67(3-4):211-4.
2004: Avilés Agustin; Nambo M Jesús; Neri Natividad; Talavera Alejandra; Castañeda Claudia; Murillo Edgar; Cleto Sergio; Huerta-Guzmán Judith
Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
Medical oncology (Northwood, London, England) 2004;21(3):269-72.
2004: Avilés Agustín; Neri Natividad; Huerta-Guzmán Judith; Fernández Raúl
Gemcitabine and cisplatin in refractory malignant lymphoma.
Oncology 2004;66(3):197-200.
2003: Avilés Agustin; Cleto Sergio; Neri Natividad; Huerta-Guzmán Judith; Talavera Alejandra; Castañeda Claudia; González Martha
Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy.
Leukemia & lymphoma 2003;44(8):1361-5.
2003: Avilés Agustin; Fernández Raúl; Calva Angel; Neri Natividad; Huerta-Guzmán Judith; Nambo M Jesús
Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma.
Hematology (Amsterdam, Netherlands) 2003;8(1):7-10.
2003: Avilés Agustin; Neri Natividad; Cuadra Ivonne; Alvarado Isabel; Fernández Raúl; Calva Angel; Huerta-Guzmán Judith
Lack of prognostic factors in follicular lymphoma.
Leukemia & lymphoma 2003;44(1):143-7.
2003: Avilés Agustin; Valdez Leticia; Halabe José; Neri Natividad; Nellen Haiko; Huerta-Guzmán Judith; Nambo M Jesús
No association between lymphoma and hepatitis C virus.
Medical oncology (Northwood, London, England) 2003;20(2):165-8.
2003: Avilés Agustin; Neri Natividad; Fernández Raúl; Calva Angel; Huerta-Guzmán Judith; Nambo M Jesús
Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Medical oncology (Northwood, London, England) 2003;20(1):13-7.
2002: Avilés A; García E L; Fernández R; Gonzalez J L; Neri N; Díaz-Maqueo J C
Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
Annals of hematology 2002;81(7):368-73.
2002: Avilés Agustin; Neri Natividad; Huerta-Guzmán Judith
Large bowel lymphoma: an analysis of prognostic factors and therapy in 53 patients.
Journal of surgical oncology 2002;80(2):111-5.
2002: Avilés Agustin; Delgado Serafin; Fernández Raúl; Talavera Alejandra; Neri Natividad; Huerta-Guzmán Judith
Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial.
European journal of haematology 2002;68(3):144-9.
2002: Avilés Agustin; Fernández Raúl; González José Luis; García Edna L; Neri Natividad; Talavera Alejandra; Diaz-Maqueo José C
Spinal cord compression as a primary manifestation of aggressive malignant lymphomas: long-term analysis of treatments with radiotherapy, chemotherapy or combined therapy.
Leukemia & lymphoma 2002;43(2):355-9.
2002: Avilés Agustin; Neri Natividad; Castañeda Claudia; Talavera Alejandra; Huerta-Guzmán Judith; González Martha
Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma.
Medical oncology (Northwood, London, England) 2002;19(1):55-8.
2001: Avilés A; Neri N
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Clinical lymphoma 2001;2(3):173-7.
2001: Neri N; Avilés A; Cleto S; Díaz N; Talavera A; García E L; Díaz-Maqueo J C
Chemotherapy plus interferon-alpha2b versus chemotherapy in the treatment of follicular lymphoma.
Journal of hematotherapy & stem cell research 2001;10(5):669-74.
2001: Avilés A; Díaz-Maqueo J C; García E L; Talavera A; Huerta-Guzmán J; Neri N
Late lethal events in patients with diffuse large B cell lymphoma: a review of 714 patients treated in a single centre.
Leukemia & lymphoma 2001;42(4):631-7.
2001: Avilés A; Talavera A; Díaz-Maqueo J C; García E L; Cleto S; Neri N
Evaluation on a six-dose treatment of anti CD 20 monoclonal antibody in patients with refractory follicular lymphoma.
Cancer biotherapy & radiopharmaceuticals 2001;16(2):159-62.
2001: Avilés A; León M I; Díaz-Maqueo J C; García E L; Cleto S; Neri N
Rituximab in the treatment of refractory follicular lymphoma -- six doses are better than four.
Journal of hematotherapy & stem cell research 2001;10(2):313-6.
2001: Avilés A; Cleto S; Huerta-Guzmán J; Neri N
Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimens.
European journal of haematology 2001;66(2):94-9.
2001: Avilés A; Neri N; García E L; Talavera A; Díaz-Maqueo J C
Treatment of refractory Hodgkin's disease with modified Stanford V program.
Medical oncology (Northwood, London, England) 2001;18(4):261-7.
2000: Huerta-Zepeda A; Talavera A; Avilés A; Neri N; Mayani H
In vitro hematopoiesis in patients with malignant lymphoma during active disease and at complete clinical remission after chemotherapy.
Leukemia & lymphoma 2000;39(5-6):613-24.
2000: Avilés A; Neri N; Cuadra I; Alvarado I; Cleto S
Second lethal events associated with treatment for Hodgkin's disease: a review of 2980 patients treated in a single Mexican institute.
Leukemia & lymphoma 2000;39(3-4):311-9.
2000: Avilés A; Díaz N R; Neri N; Cleto S; Talavera A
Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients.
Clinical and laboratory haematology 2000;22(4):215-20.
1999: Avilés A; García E L; Cuadra I; Díaz-Maqueo J C
High dose chemotherapy with G-CSF in refractory Hodgkin's disease.
Leukemia & lymphoma 1999;36(1-2):139-45.
1999: Avilés A; Halabe J
Improved prognosis in patients with acquired immunodeficiency syndrome-related lymphoma.
Cancer biotherapy & radiopharmaceuticals 1999;14(5):349-52.
1999: Avilés A; Talavera A; Díaz N R; Neri N
Interferon as maintenance therapy in refractory malignant lymphoma.
Journal of hematotherapy 1999;8(3):263-7.
1999: Avilés A; Rosas A; Huerta-Guzmán J; Talavera A; Cleto S
Dexamethasone, all trans retinoic acid and interferon alpha 2a in patients with refractory multiple myeloma.
Cancer biotherapy & radiopharmaceuticals 1999;14(1):23-6.
1999: Avilés A; Nambo M J; Halabe J
Treatment of acquired immunodeficiency syndrome-related lymphoma with a standard chemotherapy regimen.
Annals of hematology 1999;78(1):9-12.
1998: Avilés A; Díaz-Maqueo J C; Talavera A; Nambo M J; García E L
Maintenance therapy with interferon alfa 2b in Hodgkin's disease.
Leukemia & lymphoma 1998;30(5-6):651-6.
1997: Avilés A; Nambo M J; Talavera A; Garcia E L; Huerta-Guzman J; Díaz Maqueo J C
Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies.
Anti-cancer drugs 1997;8(10):937-42.
1997: Avilés A
The role of interferon as maintenance therapy in malignant lymphoma.
Medical oncology (Northwood, London, England) 1997;14(3-4):153-7.
1997: Avilés A; Díaz-Maqueo J C; Talavera A; García E L; Guzmán R; Nambo M J
Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1323-5.
1997: Avilés A; Calva A; Díaz-Maqueo J C; Talavera A; Huerta-Guzmán J; Vásquez E
Dose escalation of epirubicin in the CEOP-BLEO regimen: a controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma.
Leukemia & lymphoma 1997;25(3-4):319-25.
1996: Avilés A; Delgado S; Huerta-Guzmán J
Marginal zone B cell lymphoma of the parotid glands: results of a randomised trial comparing radiotherapy to combined therapy.
European journal of cancer. Part B, Oral oncology 1996;32B(6):420-2.
1996: Avilés A; Huerta-Guzmán J; Delgado S; Fernández A; Díaz-Maqueo J C
Improved outcome in solitary bone plasmacytomata with combined therapy.
Hematological oncology 1996;14(3):111-7.
1996: Avilés A; Guzmán R; Delgado S; Nambo M J; García E L; Díaz-Maqueo J C
Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma.
American journal of hematology 1996;52(4):275-80.
1996: Avilés A; Guzmán R; García E L; Talavera A; Díaz-Maqueo J C
Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia.
Anti-cancer drugs 1996;7(4):392-7.
1996: Avilés A; Guzmán R; García E L; Díaz-Maqueo J C
Biological modifiers (etretinate (changed from etetrinate) and alfa 2a) in the treatment of refractory cutaneous T-cell lymphoma.
Cancer biotherapy & radiopharmaceuticals 1996;11(1):21-4.
1996: Avilés A; Delgado S; Ruiz H; de la Torre A; Guzman R; Talavera A
Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy.
European journal of cancer. Part B, Oral oncology 1996;32B(1):19-23.
1995: Avilés A; Nambo M J; Talavera A; Rosas A; García E L; Díaz-Maqueo J C
GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma.
Leukemia & lymphoma 1995;17(3-4):327-30.
1995: Avilés A; Soto B; Guzmán R; García E L; Nambo M J; Díaz-Maqueo J C
Results of a randomized study of early stage Hodgkin's disease using ABVD, EBVD, or MBVD.
Medical and pediatric oncology 1995;24(3):171-5.
1995: Avilés A; Talavera A; Guzmán R; Cuadra I
Treatment of refractory low grade lymphoma with chlorambucil alternating with interferon and radiotherapy.
Cancer biotherapy 1995;10(4):273-7.
1994: Avilés A; Delgado S; Nambo M J; Alatriste S; Díaz-Maqueo J C
Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma.
International journal of radiation oncology, biology, physics 1994;30(4):799-803.
1994: Avilés A; Delgado S; Fernández A; Nambo M J; Rosas A
Combined therapy for angioimmunoproliferative lesions.
European journal of cancer. Part B, Oral oncology 1994;30B(5):302-4.
1994: Avilés A; Díaz-Maqueo J C; Talavera A; Nambo M J; García E L
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Leukemia & lymphoma 1994;15(1-2):153-7.
1994: Avilés A; Guzmán R; Talavera A; García E L; Díaz-Maqueo J C
Randomized study for the treatment of adult advanced Hodgkin's disease: epirubicin, vinblastine, bleomycin, and dacarbazine (EVBD) versus mitoxantrone, vinblastine, bleomycin, and dacarbazine (MVBD).
Medical and pediatric oncology 1994;22(3):168-72.
1993: Avilés A; Arévila N; Díaz Maqueo J C; Gómez T; García R; Nambo M J
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
Leukemia & lymphoma 1993;11(3-4):275-9.
1993: Avilés A; Narváez B R; Díaz-Maqueo J C; Guzmán R; Talavera A; García E L
Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
Leukemia & lymphoma 1993;9(4-5):377-80.
1992: Avilés A; Díaz-Maqueo J C; García E L; Talavera A; Guzmán R
Maintenance therapy with interferon alfa 2b in patients with diffuse large cell lymphoma.
Investigational new drugs 1992;10(4):351-5.
1992: Avilés A; Torras V; Cortés H D; Ramón Ayala J; Díaz Maqueo J C
[Lymphoblastic lymphoma in the adult]
Gaceta médica de México 1992;128(4):369-73.
1992: Avilés A; Guzmán R; García E L; Talavera A; Díaz-Maqueo J C
[The role of radiotherapy in the early stages of Hodgkin's disease]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1992;44(3):363-8.
1992: Avilés A; Zepeda G; Díaz-Maqueo J C; Rodriguez L; Guzmán R; García E L; Talavera A
Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma.
Leukemia & lymphoma 1992;7(1-2):135-8.
1992: Avilés A; Zepeda G; Guzmán R; Talavera A; García E L; Díaz-Maqueo J C
[Prognostic importance of beta-2-microglobulin in multiple myeloma]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1992;44(2):215-20.
1992: Avilés A; Díaz-Maqueo J C; Ayala J R; Cortés H D; García E L
Hodgkin's disease and acute leukemia. Is it a true association?
Archives of medical research 1992;23(1):65-8.
1991: Avilés A; Guzmán R; Huerta J; Díaz-Maqueo J C
[Retrospective analysis of prognostic factors in patients with primary lymphoma of the intestine]
Revista de gastroenterología de México 1991;56(4):217-21.
1991: Avilés A; Zepeda G; Cruz J
[Hodgkin's disease during pregnancy. Study of late effects in the newborn infants]
Boletín médico del Hospital Infantil de México 1991;48(9):622-6.
1991: Avilés A; Díaz-Maqueo J C; Talavera A; Guzmán R; García E L
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
American journal of hematology 1991;36(4):243-8.
1991: Avilés A; Díaz-Maqueo J C; Rodriguez L; García E L; Guzmán R; Talavera A
Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma.
Hematological oncology 1991;9(2):115-21.
1991: Avilés A; García E L; Talavera A; Guzmán R; Diáz-Maqueo J C
[Preinduction in the treatment of patients with malignant lymphoma]
Gaceta médica de México 1991;127(2):119-23.
1991: Avilés A; Díaz-Maqueo J C; García E L; Torras V; López-Vancell D
Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Archivos de investigación médica 1991;22(1):45-50.
1991: Avilés A; Díaz-Maqueo J C; Torras V; Ayala J R; Cortés H D
Hodgkin's disease. A historical perspective.
Archivos de investigación médica 1991;22(1):27-33.
1991: Avilés A; Díaz-Maqueo J C; Sánchez E; Córtes H D; Ayala J R
Long-term results in patients with low-grade nodular non-Hodgkin's lymphoma. A randomized trial comparing chemotherapy plus radiotherapy with chemotherapy alone.
Acta oncologica (Stockholm, Sweden) 1991;30(3):329-33.
1991: Avilés A; Huerta J; Zepeda G; Guzmán R; Díaz-Maqueo J
The role of maintenance therapy in the treatment of large-cell non-Hodgkin's lymphoma.
Acta oncologica (Stockholm, Sweden) 1991;30(8):959-62.
1990: Avilés A; Huerta J; Zepeda G; Díaz-Maqueo J C
Serum beta 2 microglobulin in solitary plasmocytomata.
Blood 1990;76(8):1663.
1990: Avilés A; Talavera A; García E L; Guzmán R; Díaz-Maqueo J C
[Alkaline phosphatase as a prognostic factor in Hodgkin's disease]
Revista de gastroenterología de México 1990;55(4):211-4.
1990: Avilés A; Huerta J; Guzmán R; Zepeda G; Díaz-Maqueo J C
[CHOP-bleo versus m-BACOD in the treatment of intermediate and high-grade malignant lymphomas]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1990;42(4):271-6.
1990: Avilés A; Díaz-Maqueo J C; Torras V; Guzman R
[Hodgkin's disease treated with chemotherapy at reduced dosage]
Sangre 1990;35(5):341-4.
1990: Avilés A; Díaz-Maqueo J C; Torras V; Rodríguez L; López Vancell D
[Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy]
Sangre 1990;35(4):245-9.
1990: Avilés A; Díaz-Maqueo J C; Torras V; García E L; Guzmán R
Non-Hodgkin's lymphomas and pregnancy: presentation of 16 cases.
Gynecologic oncology 1990;37(3):335-7.
1990: Avilés A; Díaz-Maqueo J C; Talavera A; García E L
[Granulocyte-macrophage colony-stimulating factor in the treatment of secondary bone marrow suppression in patients with lymphoma. Preliminary report]
Archivos de investigación médica 1990;21(2):133-7.
1990: Avilés A; Díaz-Maqueo J C; Torras V
[Treatment of refractory malignant lymphomas with cisplatin, vinblastine, and bleomycin]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1990;42(2):99-102.
1990: Avilés A; Díaz-Maqueo J C; Rodríguez L; García E L; Torras V; Guzmán R
Group risk classification of non-Hodgkin's lymphoma.
Archivos de investigación médica 1990;21(1):11-6.
1989: Avilés A; Díaz-Maqueo J C; Arévila-Ceballos N; García Fernández R; López-Vancell D; Torras V
[Evaluation of ventricular function in patients treated with mitoxantrone and 4'-epidoxorubicin]
Archivos del Instituto de Cardiología de México 1989;59(6):615-8.
1989: Díaz-Maqueo J C; Avilés A; García E L; Rodríguez L; López-Vancell D; Torras V; Guzmán R
[Long-term results in the treatment of lymphomas using polychemotherapy (CHOP)]
Sangre 1989;34(5):332-6.
1989: Díaz-Maqueo J C; Avilés A; Rodríguez L; López-Vancell D; García E L; Guzmán R
[Prognosis determination in patients with malignant lymphoma]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1989;41(3):235-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Agustin Avilés

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Agustin Avilés (preview)

All Publications